Drug Profile
Sodium glucose co-transporter type 2 inhibitor - follow-on - Bristol-Myers Squibb
Alternative Names: SGLT2 inhibitor - follow-on- Bristol-Myers SquibbLatest Information Update: 21 Dec 2007
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class
- Mechanism of Action Sodium-glucose transporter 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 15 Nov 2006 No development reported - Phase-I/II for Type-2 diabetes mellitus in USA (unspecified route)
- 26 May 2005 Phase-I/II clinical trials in Type-2 diabetes mellitus in USA (unspecified route)